Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Forte Biosciences, Inc. (FBRX) Long-Term Debt Repayments (2017 - 2020)

Forte Biosciences (FBRX) has disclosed Long-Term Debt Repayments for 3 consecutive years, with $417000.0 as the latest value for Q1 2020.

  • On a quarterly basis, Long-Term Debt Repayments changed N/A to $417000.0 in Q1 2020 year-over-year; TTM through Mar 2020 was $1.6 million, a N/A change, with the full-year FY2019 number at $23.2 million, up 671.83% from a year prior.
  • Long-Term Debt Repayments was $417000.0 for Q1 2020 at Forte Biosciences, down from $1.2 million in the prior quarter.
  • In the past five years, Long-Term Debt Repayments ranged from a high of $1.8 million in Q1 2017 to a low of $417000.0 in Q1 2020.
  • A 3-year average of $1.5 million and a median of $1.8 million in 2017 define the central range for Long-Term Debt Repayments.
  • Biggest YoY gain for Long-Term Debt Repayments was 0.0% in 2018; the steepest drop was 33.33% in 2018.
  • Forte Biosciences' Long-Term Debt Repayments stood at $1.8 million in 2017, then crashed by 33.33% to $1.2 million in 2018, then tumbled by 65.25% to $417000.0 in 2020.
  • Per Business Quant, the three most recent readings for FBRX's Long-Term Debt Repayments are $417000.0 (Q1 2020), $1.2 million (Q2 2018), and $1.8 million (Q1 2018).